Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.78 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.62 |
| ▸ | PAM | P19021 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL494044 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL494910 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL2379352 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL496269 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL495220 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL495893 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL494828 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL494731 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL494154 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT | |
| SCHEMBL2475385 | 1.00 | DGKA (0.78) | DGKADNM1PAMTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 677 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116356440-B | Modified Taiji stone and application thereof in far infrared health-care degradable copolyester fiber | 浙江恒逸石化研究院有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119069696-A | Slurry composition for secondary battery positive electrode, and secondary battery | 江苏百公里新材料科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-115322351-B | Rapidly-crystallized copolyester based on thiophene dicarboxylic acid and long-chain dibasic acid, and preparation method and product thereof | 中国科学院宁波材料技术与工程研究所 | 2024-08-06 | — | — | CN | claimed |
| CN-117659912-A | Binder composition, slurry composition, electrode, and secondary battery | 上海百公里新材料科技有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-114573956-B | Preparation method of nano magnesium hydroxide modified degradable copolyester | 浙江恒逸石化研究院有限公司 | 2023-11-24 | — | — | CN | claimed |
| US-11787918-B2 | Biobased compositions | Evoco Limited (CA) | 2023-10-17 | — | — | US | claimed |
| CN-116706072-A | Binder composition for secondary battery electrode, slurry composition, electrode, and secondary battery | 上海百公里新材料科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116356440-A | Modified Taiji stone and application thereof in far infrared health-care degradable copolyester fiber | 浙江恒逸石化研究院有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-113194719-B | Method for controlling pests and mites, and aerosol for controlling pests and mites | 大日本除虫菊株式会社 | 2023-01-17 | — | — | CN | claimed |
| CN-115568465-A | Method for controlling pests and mites, and aerosol for controlling pests and mites | 大日本除虫菊株式会社 | 2023-01-06 | — | — | CN | claimed |
| US-20030170308-A1 | Hydrophobic phase comprises (i) a hydrophobic polymer, (ii) a plasticizer, (iii) a tackifying resin, and (iv) an optional antioxidant; and a hydrophilic phase; wound dressings, transdermal drug delivery | COLUMBUS INVESTMENT HOLDINGS SA (CH) | 2003-09-11 | — | — | US | claimed |
| EP-1322349-A2 | PROTECTANT FILM FOR SKIN | Coloplast Corporation (US) | 2003-07-02 | — | — | EP | claimed |
| EP-0606923-B1 | Method for the preparation of melt processable biodegradable compositions | MCNEIL PPC INC (US) | 2003-04-02 | — | — | EP | claimed |
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | ECOLAB USA INC. | 2003-01-30 | — | — | US | claimed |
| WO-2003005818-A1 | IN SITUMONO-OR DIESTER DICARBOXYLATE COMPOSITIONS | ECOLAB INC. (US) | 2003-01-23 | — | — | WO | claimed |
| WO-2002087645-A1 | HYDROGEL COMPOSITIONS | A.V. TOPCHIEV INSTITUTE OF PETROCHEMICAL SYNTHESIS (RU) | 2002-11-07 | — | — | WO | claimed |
| WO-2002026278-A2 | PROTECTANT FILM FOR SKIN | COLOPLAST CORPORATION (US) | 2002-04-04 | — | — | WO | claimed |
| US-6358503-B1 | TO PRODUCE A PROTECTIVE FILM FOR SKIN WHEN APPLIED TO THE SKIN OF A USER | COLOPLAST CORP. | 2002-03-19 | — | — | US | claimed |
| EP-0606923-A2 | Melt processable biodegradable compositions and articles made therefrom | McNEIL-PPC, INC. (US) | 1994-07-20 | — | — | EP | claimed |
| US-4058122-A | Osmotic system with laminated wall formed of different materials | ALZA CORPORATION (US) | 1977-11-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030021853-A1 | In situ mono-or diester dicarboxylate compositions | DDC, HCAR3, ACMSD | DGKA 109/4885DNM1 471/4885PAM 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.